Skip to main content

Table 4 Patient survival and pancreas and kidney graft survival according to the T1DM SPK, T2DM SPK and T2DM KTA groups

From: Short and long-term metabolic outcomes in patients with type 1 and type 2 diabetes receiving a simultaneous pancreas kidney allograft

A: Patient survival according to the T1DM SPK T2DM SPK and T2DM KTA groups.

Patient Survival

T1DM SPK

T2DM SPK

T2DM KTA

p-value

 1-y

89.9%

91.7%

92.3%

< 0.01

 3-y

89.9%

83.3%

73.1%

 

 5-y

88.8%

83.3%

69.2%

 

B: Pancreas Graft survival according to the T1DM SPK T2DM SPK and T2DM KTA groups.

Pancreas Graft

T1DM SPK

T2DM SPK

p-value

 

Survival

 1-y

83.1%

91.7%

0.71

 

 3-y

79.8%

83.3%

  

 5-y

78.7%

83.3%

  

C: Kidney graft survival according to the T1DM SPK T2DM SPK and T2DM KTA groups.

Kidney Graft

T1DM SPK

T2DM SPK

T2DM KTA

p-value

survival

 1-y

88.8%

91.7%

80.8%

< 0.01

 3-y

85.4%

83.3%

65.4%

 

 5-y

79.8%

83.3%

57.7%

Â